Phio Pharmaceuticals Corp. (PHIO)
1.17
-0.01
(-0.85%)
USD |
NASDAQ |
Aug 24, 16:00
1.15
-0.02
(-1.71%)
After-Hours: 20:00
Phio Pharmaceuticals Profit Margin (Quarterly)
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2019 | -10.09K% |
| December 31, 2018 | |
| September 30, 2018 | -2.62K% |
| June 30, 2018 | -3.28K% |
| March 31, 2018 | -9.73K% |
| December 31, 2017 | -13.35K% |
| September 30, 2017 | |
| June 30, 2017 | |
| March 31, 2017 | |
| December 31, 2016 | |
| September 30, 2016 | |
| June 30, 2016 | -24.58K% |
| March 31, 2016 | -22.31K% |
| December 31, 2015 |
| Date | Value |
|---|---|
| September 30, 2015 | |
| June 30, 2015 | |
| March 31, 2015 | -8.66K% |
| December 31, 2014 | -16.46K% |
| September 30, 2014 | -13.79K% |
| June 30, 2014 | -16.72K% |
| March 31, 2014 | -7.88K% |
| December 31, 2013 | -8.65K% |
| September 30, 2013 | -2.24K% |
| June 30, 2013 | -871.6% |
| March 31, 2013 | -27.16K% |
| December 31, 2012 | -4.28K% |
| September 30, 2012 | -2.88K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Imunon, Inc. | -- |
| Agenus, Inc. | -1.64% |
| Amgen, Inc. | 23.59% |
| Anika Therapeutics, Inc. | 10.15% |
| BioCryst Pharmaceuticals, Inc. | 35.92% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -93.31% |
| Return on Assets | -84.88% |
| Return on Invested Capital | -93.31% |
| Return on Net Operating Assets | -131.7K% |